Paul Tudor Jones Vertex Pharmaceuticals Inc Transaction History

Tudor Investment Corp Et Al

$19.2 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $1.17 Million - $1.28 Million	-2,876 Reduced 10.89%	23,529 $9.84 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $2.38 Million - $2.85 Million	-6,950 Reduced 20.84%	26,405 $10.7 Million
Q3 2023 Nov 15, 2023	BUY	$338.18 - $362.46 $11.3 Million - $12.1 Million	33,355 New	33,355 $11.6 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $2.17 Million - $2.44 Million	7,580 New	7,580 $2.19 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $5.25 Million - $6.63 Million	-29,658 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $5.38 Million - $6.02 Million	29,658 New	29,658 $5.38 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $3.24 Million - $3.82 Million	-17,262 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $6.01 Million - $7.01 Million	-29,041 Reduced 62.72%	17,262 $3.71 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $8.4 Million - $11.2 Million	40,600 Added 711.91%	46,303 $10.9 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $532,774 - $631,660	-2,084 Reduced 26.76%	5,703 $1.55 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $582,865 - $764,643	-2,585 Reduced 24.92%	7,787 $2.26 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $1.05 Million - $1.31 Million	-5,276 Reduced 33.72%	10,372 $2.47 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $2.61 Million - $3.5 Million	15,648 New	15,648 $3.43 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $1.04 Million - $1.24 Million	-6,359 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $295,161 - $373,464	-1,943 Reduced 23.4%	6,359 $1.05 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $1.56 Million - $1.79 Million	-9,286 Reduced 52.8%	8,302 $1.6 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $2.21 Million - $2.58 Million	15,157 Added 623.49%	17,588 $2.99 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $1.21 Million - $1.41 Million	-7,985 Reduced 76.66%	2,431 $396,000
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $1.43 Million - $1.62 Million	10,416	10,416 $1.56 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account